Ultimately, Dahlberg entered into the settlement announced today, which, if approved by the federal district court, will end that litigation. In addition, Dahlberg would be prohibited from violating the 1976 Commission order. The Commission vote to accept the proposed consent decree was 5-0. Commissioner Mary L. Azcuenaga concurred, although said in a statement that she believes the safe harbor for FDA-approved claims is too narrow. This consent decree is for settlement purposes only and does not constitute an admission by the defendant of a law violation.
Consent decrees have the force of law when signed by the judge.